Charles Butler

Charles Butler has a diverse work experience spanning over several companies and roles. Charles currently holds the position of Vice President, Investor Relations at Atossa Therapeutics, Inc. Charles previously served as the Vice President, Investor Relations & Communications at IN8bio. Charles also has experience as an Investor Relations and Corporate Communications Consultant during their time of self-employment. Prior to that, they held the role of Vice President, Corporate Communications & Investor Relations at Adverum Biotechnologies, Inc.

Before transitioning to the biotech industry, Charles held the position of Senior Vice President in the Biotechnology, Life Sciences, and Healthcare division at ICR. Charles also worked as the Vice President of Investor Relations at Castlight Health.

Charles' career began in the healthcare sector, where they were the Head of Public Relations for the Clorox Healthcare/B2B Division at The Clorox Company. Charles also served as the Vice President, Corporate Communications & Investor Relations at Exelixis, Inc. during their ten-year tenure at the company.

In their earlier years, Charles worked as the Managing Director of the Healthcare Practice at Ogilvy Public Relations. Charles started their career as a Legislative Assistant at the Biotechnology Industry Organization.

Throughout their career, Charles has demonstrated expertise in investor relations, corporate communications, public relations, and strategic messaging.

Charles Butler attended the New Mexico Military Institute where they earned a high school degree. Later, they pursued a degree in Political Science and Government at The George Washington University. However, specific start and end years for both their high school and university education are not provided.